Amsterdam

• The effect of [18F]F-FAPI PET-CT on management in patients with potentially resectable biliary tract cancers: prospective multicenter study … Recruiting
  2023-507938-24-00 5 2024-11-29 Cholangiocarcinoma
• Oil- based versus water-based contrast media for hysterosalpingography (HSG) in infertile women with unevaluated indications: a randomized c … Recruiting
  2024-512571-12-00 6 2024-11-29 Infertility
• Amyloid pathology in cognitively normal elderly subjects (PreclinAD) Recruiting
  2024-518559-41-01 4 2024-11-29 Healthy controls (investigating preclinical Alzheimer's Disease)
• A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting
  2023-508191-11-00 5 2024-11-28 Systemic lupus erythematosus (SLE)
• Iberdomide combined with low-dose cyclophosphamide and dexamethasone: ICON study Recruiting
  2023-508902-66-00 4 2024-11-28 relapsed / refractory multiple myeloma
• [18F]PEG-folate PET-CT imaging for monitoring of therapy response in Rheumatoid Arthritis patients Recruiting
  2024-513537-21-02 4 2024-11-27 Rheumatoid Arthritis
• Imaging of inflamed arteries in giant cell arteritis and inflamed joints in rheumatoid arthritis with a PET/CT scan. Recruiting
  2024-514489-38-01 4 2024-11-26 giant cell arteritis
• Effectiveness of ambroxol in children and adults with Gaucher disease 3: n-of-1 series Recruiting
  2024-514012-28-00 5 2024-11-25 Gaucher disease type 3
• Study of Targeted Therapies for the Treatment of Adult Participants with Moderate to Severe Crohn’s Disease Recruiting
  2024-513009-30-00 4 2024-11-21 Moderate to Severe Crohn’s Disease
• Phase 1 study to evaluate [18F]ACI-19626 as a potential PET radioligand for imaging TDP-43 inclusions in the brain of patients with suspecte … Recruiting
  2024-513097-21-00 1 2024-11-20 Alzheimer's Disease
• The PREDMETH trial: Effectiveness of methotrexate versus prednisone as first-line therapy for pulmonary sarcoidosis – A randomized controlle … Recruiting
  2024-514055-15-00 6 2024-11-19 Pulmonary sarcoidosis
• Specifying the Anti-inflammatory Effects of Ziltivekimab (SPIDER) Recruiting
  2024-515893-29-01 10 2024-11-19 Coronary artery disease
• REVERSE: a randomized controlled trial (RCT) to ameliorate treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Rec … Recruiting
  2024-511042-39-00 4 2024-11-13 Post-traumatic stress disorder (PTSD)
• Macrophage imaging GCA Recruiting
  2024-514491-40-00 4 2024-11-12 giant cell arteritis
• A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-fibrosis) Recruiting
  2023-509912-27-00 5 2024-11-07 Metabolic Dysfunction-Associated Steatotic Liver Disease(MASH) / Nonal
• Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH (ENLIGHTEN-Cirrhosis) Recruiting
  2023-510395-31-00 5 2024-10-30 Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Compensat
• A trial to test the effect of obicetrapib/ezetimibe on coronary plaque characteristics on coronary computerized tomography angiography in pe … Recruiting
  2023-508475-36-00 5 2024-10-29 Atherosclerotic Cardiovascular Disease
• CHASIT Recruiting
  2024-516940-24-00 4 2024-10-29 locally advanced urothelial cancer.
• Timing of start of systemlc treatment for asymptomatic MEtastasized PANcreatic cancer (TIMEPAN): a prospective multicenter patient preferenc … Recruiting
  2023-509465-20-00 5 2024-10-28 metastatic pancreatic cancer
• DAROTAXEL Recruiting
  2024-516939-28-00 4 2024-10-28 metastatic castration-resistant prostate cancer
• The Hyperbaric Oxygen in HAMstring injury (HOTHAM) trial Recruiting
  2023-509610-11-00 5 2024-10-27 Acute hamstring injury
• Preventing liver recurrence after partial hepatectomy for intrahepatic cholangiocarcinoma using adjuvant hepatic arterial infusion pump chem … Recruiting
  2024-513726-33-00 4 2024-10-25 Intrahepatic cholangiocarcinoma (iCCA)
• DISTINCT: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or t … Recruiting
  2023-510186-98-00 6 2024-10-23 Venous thromboembolism
• A study to learn more about how well sevabertinib works and how safe it is compared with standard treatment, in participants who have advanc … Recruiting
  2024-511319-91-00 5 2024-10-23 Advanced non-small cell lung cancer with HER2 (ERBB2) mutation

Showing 409–432 of 1,112 trials